Spinal muscular atrophy (SMA) treatment Spinraza (nusinersen) was approved recently by the Korean Ministry of Food and Drug Safety, Biogen Korea announced. The treatment is the first (and only) ... Read more
Biogen and Ionis Pharmaceuticals, the companies that developed the new spinal muscular atrophy therapy Spinraza (nusinersen), will continue their partnership under a new agreement. “We are pleased to extend our collaboration ... Read more
Spinraza (nusinersen) was granted the 2017 Prix Galien USA Award for Best Biotechnology Product in recognition of its achievement in scientific innovation for the treatment of spinal muscular atrophy ... Read more
Spotlight Innovation has entered into a sponsored research agreement with Indiana University to develop safe and effective therapeutic options for the treatment of spinal muscular atrophy.
The partnership will seek ... Read more
The new spinal muscular atrophy (SMA) treatment Spinraza has been recommended for European approval by the Committee for Medicinal Products for Human Use (CHMP), which is part of the European ... Read more
In their most recent podcast, the team at Muscle Owl talk about the latest Spinraza news. The European Medical Agency (EMA) has approved the use of Spinraza for all types of ... Read more
Pin It on Pinterest